Abhijit A. Patel

Yale University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index2.4kcitations84works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(44), Lung Cancer Treatments and Mutations(22), Cancer Immunotherapy and Biomarkers(12), Glycosylation and Glycoproteins Research(11), Immunotherapy and Immune Responses(8)

Publications84 total

Induction FOLFIRINOX and SBRT for borderline/locally advanced pancreatic cancer.
Journal of Clinical Oncology·2026
P1.07.36 A Three-Gene Signature Predicting Local Recurrence in Stage I-III NSCLC Patients Treated With Radiation Therapy
Journal of Thoracic Oncology·2025
Genomic Predictors of Brain Metastases in Non-Small Cell Lung Cancer: Implications for Early Detection and Targeted Surveillance
International Journal of Radiation Oncology*Biology*Physics·2025
Prediction of Lymph Node Metastasis in Non–Small Cell Lung Carcinoma Using Primary Tumor Somatic Mutation Data
JCO Clinical Cancer Informatics·2025· 1 cited
A phase 2 study of olaparib in IDH1 and IDH2 mutant advanced chondrosarcomas and other solid tumors.
Journal of Clinical Oncology·2025
Molecular markers associated with survival in PD-L1– high non-small cell lung cancer treated with first-line immunotherapy versus chemoimmunotherapy.
Journal of Clinical Oncology·2025
Olaparib in treatment‐refractory isocitrate dehydrogenase 1 (<i>IDH1</i>)– and <i>IDH2</i>‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial
Cancer·2025· 7 citedOpen Access
A Comparison of Machine Learning Models to Predict Lymph Node Metastasis with Primary Tumor Transcriptome in Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics·2024Open Access
Linoleoyl-lysophosphatidylcholine suppresses immune-related adverse events due to immune checkpoint blockade
2024· 1 citedOpen Access
Single-stranded pre-methylated 5mC adapters uncover the methylation profile of plasma ultrashort Single-stranded cell-free DNA
Nucleic Acids Research·2024· 5 citedOpen Access
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors
JCO Precision Oncology·2024· 1 citedOpen Access
Abstract B040: NCI 10129: A Phase 2 Study of the PARP inhibitor Olaparib (AZD2281) in IDH1 and IDH2 mutant advanced solid tumors
Molecular Cancer Therapeutics·2023· 2 cited
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer
Cell Reports Medicine·2023· 38 citedOpen Access
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
Cell Reports Medicine·2023· 178 citedOpen Access
Suppl. Table 1 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Suppl. Table 1 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
legends from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Table S5 from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
Suppl Fig. 1 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Data from Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Azeet Narayan(19), Scott Gettinger(9), David Y. Zhang(8), Sarah B. Goldberg(7), Roy H. Decker(7), Nicholas Carriero(7), Adam J. Kole(6), Katerina Politi(5), Roy S. Herbst(5), Lucia R. Wu(5), Sherry X. Chen(5), Cecilia López Sambrooks(5), Marta Baro(5), Amanda Quijano(5), Patricia Greninger(5), Regina K. Egan(5), Cyril H. Benes(5), W. Mark Saltzman(5), Joseph N. Contessa(5), S. Percy Ivy(5)